Johns Hopkins Diabetes Guide
SGLT2 Inhibitors
INDICATIONS
FDA
FDA
- Type 2 diabetes mellitus
NON-FDA APPROVED USES
NON-FDA APPROVED USES
None established
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: April 5, 2021
Citation
Patel, Nisha K, et al. "SGLT2 Inhibitors." Johns Hopkins Diabetes Guide, 2021. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547172/all/SGLT2_Inhibitors.
Patel NK, Giles M, Pinto B. SGLT2 Inhibitors. Johns Hopkins Diabetes Guide. 2021. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547172/all/SGLT2_Inhibitors. Accessed September 22, 2023.
Patel, N. K., Giles, M., & Pinto, B. (2021). SGLT2 Inhibitors. In Johns Hopkins Diabetes Guide https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547172/all/SGLT2_Inhibitors
Patel NK, Giles M, Pinto B. SGLT2 Inhibitors [Internet]. In: Johns Hopkins Diabetes Guide. ; 2021. [cited 2023 September 22]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547172/all/SGLT2_Inhibitors.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - SGLT2 Inhibitors
ID - 547172
A1 - Patel,Nisha,PharmD, MBA, BCPS
AU - Giles,Monica,M.D.
AU - Pinto,Brian,Pharm.D.
Y1 - 2021/04/05/
BT - Johns Hopkins Diabetes Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_Diabetes_Guide/547172/all/SGLT2_Inhibitors
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
